Evaluation of Trimethoprim-sulphamethoxazole Compound in Treatment of Salmonella InfectionsBr Med J 1971; 3 doi: https://doi.org/10.1136/bmj.3.5772.451 (Published 21 August 1971) Cite this as: Br Med J 1971;3:451
- A. M. Geddes,
- R. Fothergill,
- J. A. D. Goodall,
- P. R. Dorken
Fifty patients suffering from infections caused by various salmonella species were treated with trimethoprim-sulphamethoxazole compound. Twenty-three had enteric fever and two were biliary carriers of Salmonella typhi. The other 25 suffered from infections caused by salmonella species other than S. typhi or S. paratyphi B. Twenty-one of the patients with enteric fever responded clinically to the drug, one failed treatment, and one died. Two patients suffering from typhoid fever relapsed and three temporarily excreted S. typhi in stools following treatment. One of the typhoid carriers was successfully treated. All patients with infections caused by salmonella species other than S. typhi or S. paratyphi B responded to treatment but 17 continued to excrete the organism in their stools after the course of trimethoprim-sulphamethoxazole compound. Four patients developed rashes during therapy and two became anaemic.